Neurofilament light chain (NEFL) protein is one of the neurofilament-core-subunits, forming heterodimers. Toxic neurofilament-accumulation is a hallmark of many neurodegenerative disorders and the potential of NEFL to serve as a serum biomarker in different neurological disorders was investigated. NEFL mutations cause demyelinating, axonal and intermediate forms of Charcot-Marie-Tooth disease (CMT), whereby most of the mutations are dominant missense variants functioning through a gain-of-function mechanism by perturbing neurofilament assembly and organelle transportation in axons. Muscular involvement is described as a clinical feature in CMT2E patients mostly recognized as a secondary effect but overlapping myopathic and neurogenic findings were described in some cases suggesting that NEFL-mutations might be also causative for heterogeneous neuromuscular diseases. However, studies focusing on NEFL-based myopathological changes are still rare. Molecular genetic testing, histopathological, ultra-morphological and muscle proteome studies were done in an 8-year-old boy presenting with muscle weakness, myalgia and cramps. Phenotyping revealed reduced endurance (walking distance <500m), muscle stiffness accompanied by slowly progressive gait disturbances, brisk reflex levels, sensory ataxia, pes cavus, small CMAP, slightly reduced NCV and prolonged distal latencies. CK was 205 U/l. A heterozygous de novo NEFL variant (c310.T>G, p.Phe104Val) was identified. Electron microscopy showed focal Z-band alterations and minicores in some myofibers indicative for myofibrillar disintegration. Proteomic findings are indicative for a vulnerability of proteins beyond cytoskeleton. Our findings provide new morphological and biochemical insights into vulnerability of (proximal) muscle upon the presence of a dominant NEFL missense mutation and support the concept that NEFL might be causative for heterogeneous neuromuscular diseases.